Tissue Engineering Market

Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials.

Tissue Engineering Market contains market size and forecasts of Tissue Engineering in global, including the following market information:

Global Tissue Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Tissue Engineering Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Tissue Engineering companies in 2021 (%)

The global Tissue Engineering market was valued at 27800 million in 2021 and is projected to reach US$ 87020 million by 2028, at a CAGR of 17.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Synthetic Materials Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tissue Engineering include Allergan, Integra Lifesciences, C. R. Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics, Cryolife, ACell and Biocomposites, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tissue Engineering manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tissue Engineering Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tissue Engineering Market Segment Percentages, by Type, 2021 (%)

Synthetic Materials

Biologically Derived Materials

Others

Global Tissue Engineering Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tissue Engineering Market Segment Percentages, by Application, 2021 (%)

Neurology

Cardiology and Vascular

Skin and Integumentary

Orthopedics, Musculoskeletal and Spine

Others

Global Tissue Engineering Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Tissue Engineering Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tissue Engineering revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Tissue Engineering revenues share in global market, 2021 (%)

Key companies Tissue Engineering sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Tissue Engineering sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Allergan

Integra Lifesciences

C. R. Bard

Zimmer Biomet

Organogenesis

Osiris Therapeutics

Cryolife

ACell

Biocomposites

DSM

Episkin

J-TEC

Athersys

Biotime

B. Braun

International Stem Cell

Bio Tissue Technologies